BRAINBox TBI Diagnostic/Prognostic Test
Diagnosis and prognosis of mild Traumatic Brain Injury (mTBI/Concussion)
Key Facts
About BRAINBox Solutions
BRAINBox Solutions is a private, clinical-stage diagnostics company developing an integrated, multi-modality test for mild traumatic brain injury (concussion). Its platform combines blood-based biomarkers—measurable on both lab systems and a proprietary point-of-care instrument—with tablet-based neurocognitive assessments, all integrated via an AI-driven algorithm to deliver diagnostic and prognostic information. Founded in 2017 and based in Raleigh, North Carolina, the company is advancing its lead program through a pivotal clinical trial (HeadSMART II), supported by $23 million in recent funding. BRAINBox aims to establish a new standard of objective care in the large and underserved TBI market.
View full company profile